← Back to headlines
BioNxt Provides Update on Sublingual Drug Delivery Pipeline
BioNxt has issued an update on the development, intellectual property, and commercial progress of its sublingual drug delivery pipeline, detailing advancements in its pharmaceutical projects.
17 Aug, 10:40 — 17 Aug, 10:40
Related Stories
US States Sue Meta Over Alleged Exploitation of Children on Social Media
22m ago
Czech Photographer's Perseids Image Selected as NASA's Astronomy Picture of the Day
31m ago
OpenAI Launches ChatGPT for Teens with Enhanced Safety Features
34m ago
Anthropic's Pre-IPO Credit Facility Expected to Exceed $10 Billion
40m ago